Interpace Biosciences (IDXG) Competitors

Interpace Biosciences (NASDAQ:IDXG) and Laboratory Co. of America (NYSE:LH) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, community ranking, valuation and risk.

Do institutionals & insiders hold more shares of IDXG or LH?

5.7% of Interpace Biosciences shares are held by institutional investors. Comparatively, 95.9% of Laboratory Co. of America shares are held by institutional investors. 5.5% of Interpace Biosciences shares are held by insiders. Comparatively, 0.8% of Laboratory Co. of America shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Which has more risk & volatility, IDXG or LH?

Interpace Biosciences has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Laboratory Co. of America has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500.

Does the MarketBeat Community favor IDXG or LH?

Laboratory Co. of America received 310 more outperform votes than Interpace Biosciences when rated by MarketBeat users. However, 72.83% of users gave Interpace Biosciences an outperform vote while only 63.92% of users gave Laboratory Co. of America an outperform vote.

Company	Underperform	Outperform
Interpace Biosciences	Outperform Votes 319 72.83%	Underperform Votes 119 27.17%
Laboratory Co. of America	Outperform Votes 629 63.92%	Underperform Votes 355 36.08%

Does the media refer more to IDXG or LH?

In the previous week, Laboratory Co. of America had 12 more articles in the media than Interpace Biosciences. MarketBeat recorded 13 mentions for Laboratory Co. of America and 1 mentions for Interpace Biosciences. Laboratory Co. of America's average media sentiment score of 1.16 beat Interpace Biosciences' score of 0.00 indicating that Laboratory Co. of America is being referred to more favorably in the news media.

Company	Overall Sentiment
Interpace Biosciences	Neutral
Laboratory Co. of America	Positive

Is IDXG or LH more profitable?

Interpace Biosciences has a net margin of 10.39% compared to Laboratory Co. of America's net margin of 5.73%. Laboratory Co. of America's return on equity of 15.29% beat Interpace Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Interpace Biosciences	10.39%	-8.09%	37.14%
Laboratory Co. of America	5.73%	15.29%	7.01%

Do analysts rate IDXG or LH?

Laboratory Co. of America has a consensus target price of $274.00, suggesting a potential upside of 5.05%. Given Laboratory Co. of America's stronger consensus rating and higher possible upside, analysts plainly believe Laboratory Co. of America is more favorable than Interpace Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Interpace Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.86

Which has stronger earnings & valuation, IDXG or LH?

Laboratory Co. of America has higher revenue and earnings than Interpace Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Interpace Biosciences	$40.21M	0.08	$800K	N/A	N/A
Laboratory Co. of America	$13.18B	1.66	$746M	$8.65	30.15

Summary

Laboratory Co. of America beats Interpace Biosciences on 13 of the 17 factors compared between the two stocks.